Literature DB >> 10762019

Recruiting subjects in cancer prevention and control studies.

M T Ruffin1, J Baron.   

Abstract

Recruitment of subjects is a critical aspect of prevention trials that is often overlooked by investigators. As a consequence, accrual time is often extended, workloads may become heavy, and resource utilization is increased in an effort to complete projects. Recruitment of healthy subjects in cancer prevention and control studies presents unique issues that need to be considered. The barriers to recruitment include participant issues, physician variables, features of the study design, and characteristics of the health care system in the United States. The authors provide their experience in overcoming these difficulties.

Entities:  

Mesh:

Year:  2000        PMID: 10762019     DOI: 10.1002/(sici)1097-4644(2000)77:34+<80::aid-jcb14>3.0.co;2-e

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN: 0733-1959


  5 in total

1.  Recruitment strategies and rates of a multi-site behavioral intervention for adolescents and young adults with cancer.

Authors:  Verna L Hendricks-Ferguson; Brooke O Cherven; Debra S Burns; Sharron L Docherty; Celeste R Phillips-Salimi; Lona Roll; Kristin A Stegenga; Molly Donovan Stickler; Joan E Haase
Journal:  J Pediatr Health Care       Date:  2012-06-02       Impact factor: 1.812

2.  Process evaluation of recruitment for a cancer screening trial in primary care.

Authors:  Aimee S James; Christine M Daley; Kimberly Engelman; K Allen Greiner; Edward Ellerbeck
Journal:  Health Promot Pract       Date:  2011-04-06

3.  Recruiting low-income healthy women to research: an exploratory study.

Authors:  Galen Joseph; Celia P Kaplan; Rena J Pasick
Journal:  Ethn Health       Date:  2007-11       Impact factor: 2.772

4.  Motivation and frustration in cardiology trial participation: the patient perspective.

Authors:  Silmara Meneguin; Luiz Antônio Machado Cesar
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

5.  Who wants to join preventive trials?--Experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757].

Authors:  Sirpa-Liisa Hovi; Matti Hakama; Piret Veerus; Mati Rahu; Elina Hemminki
Journal:  BMC Med Res Methodol       Date:  2005-04-12       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.